Everyone generally agrees that aging is a natural part of the life cycle. In fact, aging is considered graceful, an indication of wisdom, an expert on all things, especially life. Aging for some is a beautiful, natural process, but for others, aging is not all it’s cracked up to be. For some aging can be heartbreaking and unbearable, filled with pain, anguish, and confusion.
Aging comes with a variety of complications, namely Alzheimer’s, arthritis, osteoporosis, cancer and high blood pressure. These conditions can make the quality of life in elderly people less than desirable. But conventional medicine has done nothing but help treat these conditions after they exist, instead of actively attempting to prevent them in the first place. Which means that anyone diagnosed with any of these conditions faces a tough and challenging future if they have one at all.
But there are some in the medial industry who are hoping to change the status quo. Jason Hope is one such person. Hope is an Arizona philanthropist and entrepreneur based in Scottsdale who is committed to finding ways in which the healthcare industry can address the complications of aging. In December 2010, Hope embarked on a journey with an organization called the SENS Research Foundation.
His $500,000 donation made on that day, helped the organization establish a laboratory program in the United Kingdom, which in turn began using biotechnology to help counteract aging and prevent age-related illnesses.
Biotechnology examines living organisms and organic systems in order to develop new products that improve quality of life. Biotech products are also used to improve agricultural methods and increase understanding of how medicine can combat a disease.
Founded in March 2009, the SENS Research Foundation has invested in research programs dedicated to learning about the aging process, attempting to eliminate age-related illnesses and transform the public perception of aging in the hopes of innovative change.
It is in this mission that Jason Hope and the SENS Foundation have become allies. Both believe that technology, particularly biotechnology, can help repair living cells within patient’s bodies in order to prevent the effects of aging altogether. By focusing on the root causes of age-related illnesses at a cellular level, SENS hopes to eradicate these illnesses, ensuring that humans have a longer and healthier lifespan.
By consistently studying, researching, and developing cellular research, SENS and Jason Hope believe that humans will eventually have the opportunity to live for hundreds if not thousands of years.
With Hope’s donations, SENS and researchers have been able to develop medications known as age-breakers. Glycation end-products are substances that build up in a person’s body as he or she ages. The substance causes veins and skin to become less flexible, increasing the risk of high blood pressure, causing stiffness in the body, and other age-related complications.
Age-breakers are drugs that help eliminate glycation end-products. While researchers have been able to successfully develop these medications for small animals, they have not been able to reproduce the same results for humans. But that doesn’t mean they still won’t try.
In fact, current research has been able to identify at least one glycation end-product, glucosepane. Glucosepane is the most prevalent glycation end-product found in the human body. Researchers have been able to determine that glucosepane does, in fact, promote aging as well as severe health problems in elderly patients. This is merely the beginning of the anti-aging research movement, but it’s an amazing start.
Jason Hope understands this and is working hard to promote further research and study into the prevention of age-related illnesses, and quite possibly delay the aging process altogether.
His commitment is unmatched. When speaking about his reasons for supporting the SENS Foundation, Hope explained that seeking to treat Alzheimer’s or heart and lung diseases is only a fraction of true healthcare. Once these conditions have triggered harmful symptoms, a patient’s quality of life diminishes dramatically. But by preventing these illnesses in the first place humanity is taking an evolutionary leap forward.
It’s too soon to say whether biotechnology will help eliminate the aging process altogether, but it is safe to say that further research and studies need to be conducted so that at least, old age doesn’t have to be painful or languishing, but instead the graceful, dignifying experience it should be.
For details: www.linkedin.com/in/jasonrhope